Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Infect Genet Evol ; 27: 325-31, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25120099

RESUMEN

Canine babesiosis is a vector borne disease caused by intra-erythrocytic apicomplexan parasites Babesia canis (large form) and Babesia gibsoni (small form), throughout the globe. Apart from few sporadic reports on the occurrence of B. gibsoni infection in dogs, no attempt has been made to characterize Babesia spp. of dogs in India. Fifteen canine blood samples, positive for small form of Babesia, collected from northern to eastern parts of India, were used for amplification of 18S rRNA gene (∼1665bp) of Babesia sp. and partial ITS1 region (∼254bp) of B. gibsoni Asian genotype. Cloning and sequencing of the amplified products of each sample was performed separately. Based on sequences and phylogenetic analysis of 18S rRNA and ITS1 sequences, 13 were considered to be B. gibsoni. These thirteen isolates shared high sequence identity with each other and with B. gibsoni Asian genotype. The other two isolates could not be assigned to any particular species because of the difference(s) in 18S rRNA sequence with B. gibsoni and closer identity with Babesiaoccultans and Babesiaorientalis. In the phylogenetic tree, all the isolates of B. gibsoni Asian genotype formed a separate major clade named as Babesia spp. sensu stricto clade with high bootstrap support. The two unnamed Babesia sp. (Malbazar and Ludhiana isolates) clustered close together with B. orientalis, Babesia sp. (Kashi 1 isolate) and B. occultans of bovines. It can be inferred from this study that 18S rRNA gene and ITS1 region are highly conserved among 13 B. gibsoni isolates from India. It is the maiden attempt of genetic characterization by sequencing of 18S rRNA gene and ITS1 region of B. gibsoni from India and is also the first record on the occurrence of an unknown Babesia sp. of dogs from south and south-east Asia.


Asunto(s)
Babesia/clasificación , Babesia/genética , Babesiosis/parasitología , ADN Intergénico , Enfermedades de los Perros/parasitología , Filogenia , ARN Ribosómico 18S , Animales , Clonación Molecular , Enfermedades de los Perros/epidemiología , Perros , India/epidemiología , Datos de Secuencia Molecular , Análisis de Secuencia de ADN
2.
Res Vet Sci ; 97(2): 292-6, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25135490

RESUMEN

The Non-Structural protein 1 of Canine Parvovirus-2 (CPV2.NS1) plays a major role in viral cytotoxicity and pathogenicity. CPV2.NS1 has been proven to cause apoptosis in HeLa cells in vitro in our laboratory. Here we report that CPV2.NS1 has no toxic side effects on healthy cells but regresses skin tumors in Wistar rats. Histopathological examination of tumor tissue from CPV2.NS1 treated group revealed infiltration of mononuclear and polymorphonuclear cells with increased extra cellular matrix, indicating signs of regression. Tumor regression was also evidenced by significant decrease in mitotic index, AgNOR count and PCNA index, and increase in TUNEL positive apoptotic cells in CPV2.NS1 treated group. Further, CPV2.NS1 induced anti-tumor immune response through significant increase in CD8(+) and NK cell population in CPV2.NS1 treated group. These findings suggest that CPV2.NS1 can be a possible therapeutic candidate as an alternative to chemotherapy for the treatment of cancer.


Asunto(s)
Carcinoma de Células Escamosas/veterinaria , Enfermedades de los Perros/terapia , Terapia Genética/métodos , Parvovirus Canino/genética , Neoplasias Cutáneas/veterinaria , Proteínas no Estructurales Virales/genética , 9,10-Dimetil-1,2-benzantraceno/efectos adversos , Animales , Apoptosis , Carcinógenos , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/terapia , Modelos Animales de Enfermedad , Enfermedades de los Perros/inducido químicamente , Enfermedades de los Perros/patología , Perros , Masculino , Índice Mitótico , Ratas , Ratas Wistar , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/terapia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA